Jansitin 100 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

jansitin 100 mg filmom obalené tablety

g.l. pharma gmbh, rakúsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Jansitin 50 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

jansitin 50 mg filmom obalené tablety

g.l. pharma gmbh, rakúsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Anau 100 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

anau 100 mg filmom obalené tablety

heaton k.s., Česká republika - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Accord Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

sitagliptin accord

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, typ 2 - lieky používané pri cukrovke - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Simebetes 50 mg/850 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

simebetes 50 mg/850 mg filmom obalené tablety

alfred e. tiefenbacher (gmbh & co. kg), nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Simebetes 50 mg/1000 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

simebetes 50 mg/1000 mg filmom obalené tablety

alfred e. tiefenbacher (gmbh & co. kg), nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Tiefenbacher 100 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin tiefenbacher 100 mg filmom obalené tablety

alfred e. tiefenbacher (gmbh & co. kg), nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Tiefenbacher 50 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin tiefenbacher 50 mg filmom obalené tablety

alfred e. tiefenbacher (gmbh & co. kg), nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Tiefenbacher 25 mg filmom obalené tablety Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin tiefenbacher 25 mg filmom obalené tablety

alfred e. tiefenbacher (gmbh & co. kg), nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Jamesi 50 mg/1000 mg Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

jamesi 50 mg/1000 mg

zentiva, k.s., Česká republika - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)